A 2010 update on occult hepatitis B infection

Area of Science:

• Hepatology
• Virology
• Immunology

Background:

• Occult hepatitis B virus (HBV) infection is characterized by the presence of HBV-DNA in the liver or serum, despite the absence of the surface antigen (HBsAg).
• OBI can be seropositive (anti-HBc alone or with anti-HBs) or seronegative, presenting a complex virological profile.
• The clinical relevance of OBI has been debated, particularly concerning its role in viral transmission and disease progression.

Purpose of the Study:

• To elucidate the virological and clinical significance of occult hepatitis B virus infection.
• To highlight the implications of intrahepatic viral cccDNA persistence and suppressed replication in OBI.
• To underscore the potential risks associated with OBI, including transmission and disease progression.

Main Methods:

• Characterization of OBI based on HBV serological profiles (HBsAg, anti-HBc, anti-HBs).
• Detection of HBV-DNA in liver tissue and serum.
• Analysis of viral cccDNA persistence and replication status.
• Clinical observation of OBI carriers for transmission events and disease outcomes.

Main Results:

• OBI is defined by persistent HBV-DNA without HBsAg, with varying serological profiles.
• Intrahepatic HBV cccDNA persistence and suppressed viral replication are key features of OBI.
• OBI carriers pose risks for HBV transmission via blood transfusion and organ transplantation.
• Immunosuppression can trigger hepatitis flares in OBI carriers, potentially leading to severe or fulminant hepatitis.
• Chronic necro-inflammation in OBI may contribute to cirrhosis, especially with coexisting liver damage.
• OBI is considered a risk factor for hepatocellular carcinoma (HCC) development.

Conclusions:

• Occult hepatitis B virus infection is a clinically relevant entity with significant implications for public health and patient management.
• Understanding OBI is crucial for preventing viral transmission through blood products and transplantation.
• OBI carriers require careful monitoring due to the risk of hepatitis flares, chronic liver damage progression, and HCC development.